Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 544
interventional 390
Observational 142
Registry 12

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 174
Biological 69
Behavioral 39
Drug|placebo 26
Biological|Drug 7
Other 7
Procedure 7
Device 6
Dietary Supplement 5
Drug|Procedure 5
Behavioral|Other 4
Genetic 4
Behavioral|Drug 3
Biological|placebo 3
Dietary Supplement|placebo 3
Drug|Other|Procedure|Radiation 3
Drug|Radiation 3
Device|Drug 2
Drug|Genetic 2
Drug|Other 2
Drug|Procedure|Radiation 2
Behavioral|Device|Procedure 1
Behavioral|Diagnostic Test|Drug 1
Behavioral|Dietary Supplement 1
Behavioral|Other|Procedure 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Drug|Procedure|Radiation 1
Biological|Other 1
Combination Product 1
Device|Drug|Genetic 1
Device|Drug|Other 1
Device|Drug|Procedure 1
Device|Other 1
Diagnostic Test 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 175
NA 39
United States|Canada 18
Canada 10
South Africa 10
United Kingdom 8
China 7
United States|Puerto Rico 7
France 6
Russian Federation 4
Brazil 3
Germany 3
Japan 3
Kenya 3
Spain 3
Australia 2
Australia|New Zealand 2
Botswana 2
India 2
Ireland 2
Korea, Republic of 2
Netherlands 2
Uganda 2
Argentina 1
Argentina|Brazil|India|Kenya|South Africa 1
Argentina|France|South Africa|United States|Thailand 1
Australia|France|Germany|Italy|Spain|United Kingdom 1
Australia|Germany|Italy|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Hungary|Ireland|Israel|Poland|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Germany|Hungary|Israel|Portugal|Russian Federation|Spain|Switzerland|United Kingdom 1
Austria|Denmark|France|Germany|Hungary|Israel|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
Austria|Germany|Hungary|Sweden|United Kingdom 1
Belgium 1
Belgium|Netherlands 1
Bulgaria 1
Cameroon|Kenya|Senegal|South Africa|Thailand|Uganda 1
Canada|Germany|Italy|Spain 1
Chile|France|United States|Argentina|Australia|Austria|Brazil|Germany|Guatemala|Hungary|Malaysia|Panama|Puerto Rico|Romania|South Africa|Spain|Taiwan|Thailand|United Kingdom 1
China|Korea, Republic of 1
China|Korea, Republic of|Singapore 1
Czechia|Denmark|France|Greece|Slovakia|Sweden|United Kingdom 1
Denmark 1
Egypt 1
Estonia 1
Finland|Sweden 1
France|Germany|Australia|Czechia|Hungary|Poland|Spain|Sweden|United Kingdom 1
France|Germany|Italy|Poland|Romania|Spain|Sweden|Switzerland|United Kingdom 1
France|Germany|Poland|Romania|Spain|Sweden|Switzerland|United Kingdom 1
Ghana 1
India|South Africa|Uganda 1
Iran, Islamic Republic of 1
Israel|Italy 1
Italy|South Africa|Spain|Thailand 1
Jamaica 1
Kenya|Malawi|Rwanda|South Africa|Tanzania 1
Kenya|Malawi|Uganda|Zambia|Zimbabwe 1
Malaysia 1
Mozambique 1
Norway 1
Puerto Rico|United States 1
Romania 1
South Africa|Zimbabwe 1
Spain|Sweden|Switzerland|Puerto Rico|United States|Belgium|Canada|France|Poland|United Kingdom 1
Swaziland 1
Sweden 1
Taiwan 1
Tanzania 1
Thailand 1
Thailand|Argentina|Brazil|Mexico|Peru|Russian Federation|South Africa 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Romania|Russian Federation|South Africa|Spain|Taiwan|United Kingdom 1
United States|Argentina|Austria|Brazil|China|France|Germany|Mexico|Puerto Rico|Russian Federation|South Africa|Thailand|Uganda|United Kingdom 1
United States|Argentina|Canada|France|Italy|Mexico|Portugal|Puerto Rico|Russian Federation|South Africa|Spain|Thailand|United Kingdom 1
United States|Argentina|Colombia|Germany|Mexico|Peru|Romania|Russian Federation|South Africa|Spain 1
United States|Argentina|France|Guatemala|Mexico|Peru|Puerto Rico|Romania|Russian Federation|South Africa|Ukraine 1
United States|Argentina|South Africa|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Portugal|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Austria|Canada|Dominican Republic|Germany|Mexico|Puerto Rico|United Kingdom 1
United States|Australia|Belgium|Canada|Czech Republic|France|Germany|Greece|Ireland|Italy|Netherlands|Poland|Puerto Rico|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|France|Puerto Rico 1
United States|Australia|Puerto Rico 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Portugal|Puerto Rico|Spain|Switzerland|United Kingdom 1
United States|Belarus|Czechia|Ireland|Italy|Netherlands|Russian Federation|United Kingdom 1
United States|Belgium|Canada|France|Germany|Poland|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Belgium|Dominican Republic|France|Italy|Mexico|Portugal|Puerto Rico|Russian Federation|Thailand|Uganda|United Kingdom 1
United States|Canada|Czechia|Hungary|Poland|Russian Federation|Slovakia 1
United States|Canada|France|Germany|Portugal|Puerto Rico|Spain|United Kingdom 1
United States|Canada|France|Germany|Spain 1
United States|Canada|France|Italy|Poland|Puerto Rico|Spain 1
United States|Chile|Israel 1
United States|Dominican Republic|Russian Federation|Thailand|Uganda 1
United States|Germany|Hungary|Russian Federation|Spain 1
United States|Hungary|United Kingdom 1
United States|Kenya|Puerto Rico|South Africa 1
United States|Russian Federation 1
United States|Rwanda 1
United States|South Africa 1
United States|South Africa|Thailand 1
United States|South Africa|Thailand|Uganda|Zimbabwe 1

Sites per Study

Site_count Study_Count
1 205
2 31
3 13
4 10
5 8
6 10
7 5
8 3
9 7
10 9
11 6
12 5
13 4
14 5
15 2
16 4
17 3
18 4
19 8
20 1
22 3
23 4
24 2
25 2
26 1
27 1
28 3
31 1
32 1
34 2
36 2
37 2
39 1
41 1
44 3
48 2
49 1
50 1
51 2
56 1
62 1
76 1
80 1
81 1
82 1
87 1
89 1
90 1
99 2
129 1

Phase

Phase Study_Count
N/A 99
Phase 3 97
Phase 2 65
Phase 1 47
Phase 4 38
Phase 1/Phase 2 27
Phase 2/Phase 3 14
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 121
2 119
3 35
4 20
5 5
6 1
8 1
10 1
12 1
NA 86

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1.0 10.00 1.00000 8.00000 10.0000 3.00000 6.0000 5.0000
1st Qu. 19.5 50.00 11.75000 11.50000 30.0000 39.25000 49.2500 24.2500
Median 38.0 120.00 24.00000 27.50000 72.0000 54.50000 100.0000 41.0000
Mean 41.0 2666.63 27.79545 49.65385 126.8571 91.64286 224.6596 583.6316
3rd Qu. 61.0 400.00 41.25000 41.50000 155.0000 118.25000 294.7500 92.0000
Max. 84.0 190539.00 100.00000 280.00000 1200.0000 318.00000 1277.0000 18696.0000

Trial Group Type

group_type Group_Count
Experimental 398
Active Comparator 93
NA 86
Other 48
Placebo Comparator 34
No Intervention 30
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 160
Single Group Assignment 143
NA 58
Crossover Assignment 18
Sequential Assignment 6
Factorial Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 297
Prevention 43
Supportive Care 11
NA 10
Diagnostic 8
Basic Science 7
Health Services Research 6
Other 5
Screening 3

Observational Studies

Studies by Country

Country Study_Count
United States 54
NA 26
France 10
China 5
Germany 5
Brazil 3
Canada 3
Japan 3
Korea, Republic of 3
Lesotho 3
Switzerland 3
Kenya 2
Spain 2
United Kingdom 2
United States|Turkey 2
Australia|New Zealand 1
Austria|Canada|France|Spain|United Kingdom 1
Belgium 1
Ethiopia 1
France|Germany|Italy 1
Israel 1
Italy 1
South Africa 1
Swaziland 1
Taiwan 1
Uganda 1
United Arab Emirates 1
United States|Canada 1
United States|Chile 1
United States|India|Kenya|Thailand 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 101
2 10
3 2
4 5
5 5
6 4
7 2
8 1
9 2
10 1
17 1
19 1
23 1
27 1
29 1
30 1
38 1
44 1
90 1

Enrollment Metrics

Measure Observational
Min 0.0
1st Qu 56.5
Median 200.0
Mean 789564.8
3rd Qu 580.5
Max 99999999.0

Observation Model

observational_model Study_Count
Cohort 70
NA 38
Case-Only 11
Other 10
Case-Control 5
Family-Based 4
Case Control 2
Defined Population, Natural History 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 78
NA 30
Retrospective 19
Cross-Sectional 10
Other 4
Cross-Sectional, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
France 2
United States 2
Australia 1
Austria 1
Ethiopia 1
Germany 1
Italy 1
Kuwait 1
Mexico 1
Tanzania 1

Sites per Study

Site_count Study_Count
1 7
4 1
6 2
7 1
9 1

Enrollment Metrics

Measure Registries
Min 27.0
1st Qu 162.5
Median 499.5
Mean 724.5
3rd Qu 1053.5
Max 2000.0

Registry Model

observational_model Study_Count
Cohort 8
Case-Only 1
Case Control 1
Ecologic or Community 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 11
Other 1

Follow-up

target_duration Study_Count
1 Year 2
12 Months 2
5 Years 2
1 Day 1
15 Years 1
24 Months 1
24 Weeks 1
3 Years 1
4 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03362476 Computer-based Intervention for Alcohol-using HIV/HCV+ Women https://ClinicalTrials.gov/show/NCT03362476 Active, not recruiting New York University 2020-02-29
NCT04370795 Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus https://ClinicalTrials.gov/show/NCT04370795 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2026-09-09
NCT03408262 Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women https://ClinicalTrials.gov/show/NCT03408262 Completed Imperial College London 2020-02-10
NCT03407105 A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV) https://ClinicalTrials.gov/show/NCT03407105 Completed Bristol-Myers Squibb 2006-02-21
NCT03383380 Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome https://ClinicalTrials.gov/show/NCT03383380 Recruiting Children’s Hospital of Fudan University 2022-11-30
NCT03369327 Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus https://ClinicalTrials.gov/show/NCT03369327 Completed Tehran University of Medical Sciences 2018-09-01
NCT03335176 Feasibility of Telerehabilitation in HIV-patients https://ClinicalTrials.gov/show/NCT03335176 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2015-04-01
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT03333486 Recruiting Roswell Park Cancer Institute 2022-09-06
NCT03315078 Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency https://ClinicalTrials.gov/show/NCT03315078 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2022-12-31
NCT03314064 Phase 4 Study of Dolutegravir (DTG) in Russian Federation https://ClinicalTrials.gov/show/NCT03314064 Completed ViiV Healthcare 2018-10-01
NCT03307915 A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment https://ClinicalTrials.gov/show/NCT03307915 Active, not recruiting Janssen Vaccines & Prevention B.V. 2020-10-20
NCT03301168 Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03301168 Active, not recruiting Bellicum Pharmaceuticals 2020-02-29
NCT03277313 Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects https://ClinicalTrials.gov/show/NCT03277313 Active, not recruiting Shire 2023-05-31
NCT03266653 EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection https://ClinicalTrials.gov/show/NCT03266653 Recruiting New York Medical College 2020-12-31
NCT03266640 Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) https://ClinicalTrials.gov/show/NCT03266640 Recruiting New York Medical College 2020-12-31
NCT03266627 Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection https://ClinicalTrials.gov/show/NCT03266627 Recruiting New York Medical College 2020-12-31
NCT03250910 Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients https://ClinicalTrials.gov/show/NCT03250910 Completed National Taiwan University Hospital 2017-07-15
NCT03238079 Study of PlasmaCap IG in Adults and Children With PIDD https://ClinicalTrials.gov/show/NCT03238079 Active, not recruiting Therapure Biopharma Inc 2020-08-25
NCT03235349 Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection https://ClinicalTrials.gov/show/NCT03235349 Completed AbbVie 2018-11-15
NCT03222583 A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection https://ClinicalTrials.gov/show/NCT03222583 Completed AbbVie 2018-10-18
NCT03211689 The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease https://ClinicalTrials.gov/show/NCT03211689 Completed Stockton University 2017-12-31
NCT03211065 Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig https://ClinicalTrials.gov/show/NCT03211065 Active, not recruiting Rochester General Hospital 2019-12-31
NCT03182738 Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms https://ClinicalTrials.gov/show/NCT03182738 Completed Columbia University 2019-04-03
NCT03166449 Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT03166449 Completed University of Malaya 2015-07-31
NCT03149848 Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects https://ClinicalTrials.gov/show/NCT03149848 Completed ViiV Healthcare 2017-09-06
NCT03116347 Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects https://ClinicalTrials.gov/show/NCT03116347 Active, not recruiting Shire 2023-11-30
NCT03098654 Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania https://ClinicalTrials.gov/show/NCT03098654 Active, not recruiting Medical University of South Carolina 2021-06-30
NCT03052491 Effects of a 10 Component Dietary Supplement on Health and the Quality of Life https://ClinicalTrials.gov/show/NCT03052491 Completed Centagen, Inc. 2016-08-24
NCT03051425 Immune Benefits of Consumption of Dairy Yogurt in Elderly https://ClinicalTrials.gov/show/NCT03051425 Completed Yonsei University 2017-01-10
NCT03045861 Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults https://ClinicalTrials.gov/show/NCT03045861 Completed GlaxoSmithKline 2018-04-23
NCT03033745 Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) https://ClinicalTrials.gov/show/NCT03033745 Completed CSL Behring 2018-12-14
NCT03016806 Umbilical Cord Blood Transplantation From Unrelated Donors https://ClinicalTrials.gov/show/NCT03016806 Recruiting University of Rochester 2025-06-30
NCT02999984 Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID https://ClinicalTrials.gov/show/NCT02999984 Completed Orchard Therapeutics 2018-10-11
NCT02974998 Cape Town Young Women’s Health CoOp https://ClinicalTrials.gov/show/NCT02974998 Completed RTI International 2019-11-26
NCT02965014 NC Young Women’s CoOp https://ClinicalTrials.gov/show/NCT02965014 Active, not recruiting RTI International 2020-07-31
NCT02954640 Evaluation of the Efficacy of the Sequencing Method by Gene-panel https://ClinicalTrials.gov/show/NCT02954640 Completed Imagine Institute 2017-09-08
NCT02929069 A Unified Intervention for Young Gay and Bisexual Men’s Minority Stress, Mental Health, and HIV Risk https://ClinicalTrials.gov/show/NCT02929069 Active, not recruiting Yale University 2020-08-31
NCT02919306 Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults https://ClinicalTrials.gov/show/NCT02919306 Completed Janssen Vaccines & Prevention B.V. 2018-09-30
NCT02895204 Effect of Fermented Maillard Reacted Whey Protein on Immune Function https://ClinicalTrials.gov/show/NCT02895204 Completed Yonsei University 2016-06-30
NCT02881762 Maraviroc Efficacy for Hepatitis C https://ClinicalTrials.gov/show/NCT02881762 Completed University of Maryland, Baltimore 2019-03-27
NCT02881437 IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia https://ClinicalTrials.gov/show/NCT02881437 Completed University Hospital, Lille 2018-03-16
NCT02831673 An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) https://ClinicalTrials.gov/show/NCT02831673 Active, not recruiting ViiV Healthcare 2018-03-29
NCT02818283 Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention https://ClinicalTrials.gov/show/NCT02818283 Recruiting Ohio State University 2020-12-31
NCT02817451 DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants https://ClinicalTrials.gov/show/NCT02817451 Completed Sanofi 2019-02-22
NCT02810444 Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID https://ClinicalTrials.gov/show/NCT02810444 Completed Biotest 2020-04-01
NCT02806986 Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT02806986 Completed Grifols Therapeutics LLC 2019-05-15
NCT02771600 Pilot Study of a New Device (Buzzy®) for Procedural Pain Relief During Needle-Related Procedures in Paediatric Patients https://ClinicalTrials.gov/show/NCT02771600 Completed St. Justine’s Hospital 2018-09-15
NCT02738138 A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) https://ClinicalTrials.gov/show/NCT02738138 Completed AbbVie 2017-03-15
NCT02711228 Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules https://ClinicalTrials.gov/show/NCT02711228 Completed CSL Behring 2018-01-30
NCT02670772 Dose Optimisation of Stavudine for the Treatment of HIV Infection https://ClinicalTrials.gov/show/NCT02670772 Completed University of Witwatersrand, South Africa 2014-12-31
NCT02660281 URMC Related Haplo-identical Donor BMT https://ClinicalTrials.gov/show/NCT02660281 Recruiting University of Rochester 2025-10-31
NCT02659761 Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs https://ClinicalTrials.gov/show/NCT02659761 Recruiting University College Dublin 2020-12-31
NCT02651376 Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients https://ClinicalTrials.gov/show/NCT02651376 Completed Beijing 302 Hospital 2017-04-30
NCT02639754 Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria https://ClinicalTrials.gov/show/NCT02639754 Enrolling by invitation Medical College of Wisconsin 2020-12-31
NCT02630082 Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru https://ClinicalTrials.gov/show/NCT02630082 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-03-31
NCT02627300 Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial https://ClinicalTrials.gov/show/NCT02627300 Completed Octapharma 2019-09-05
NCT02604810 Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT02604810 Completed Grifols Therapeutics LLC 2017-09-30
NCT02600325 Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV https://ClinicalTrials.gov/show/NCT02600325 Completed Erasmus Medical Center 2018-04-01
NCT02990819 Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT02990819 Recruiting Children’s Hospital of Philadelphia 2023-12-31
NCT02494986 A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies https://ClinicalTrials.gov/show/NCT02494986 Recruiting Janssen Sciences Ireland UC 2030-12-31
NCT02572401 Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men https://ClinicalTrials.gov/show/NCT02572401 Completed University of Pennsylvania 2013-06-30
NCT02571595 A Sleep Program to Improve Sleep Quality in People With HIV https://ClinicalTrials.gov/show/NCT02571595 Active, not recruiting McGill University 2020-01-31
NCT02571504 Cognitive Training for the Remediation of Functional Brain Health in HIV https://ClinicalTrials.gov/show/NCT02571504 Completed McGill University 2017-05-31
NCT02561286 Being Responsible for Ourselves HIV Risk Reduction for Black MSM https://ClinicalTrials.gov/show/NCT02561286 Completed University of Pennsylvania 2012-05-31
NCT02741128 Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults https://ClinicalTrials.gov/show/NCT02741128 Active, not recruiting Sanofi 2022-06-30
NCT02016924 Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants https://ClinicalTrials.gov/show/NCT02016924 Active, not recruiting Gilead Sciences 2021-10-31
NCT02538952 Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons https://ClinicalTrials.gov/show/NCT02538952 Completed Centers for Disease Control and Prevention 2017-07-01
NCT02537236 Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet. https://ClinicalTrials.gov/show/NCT02537236 Completed Instituto Mexicano del Seguro Social 2009-05-31
NCT02508584 Personalized Immunotherapeutic for Antibiotic-resistant Infection https://ClinicalTrials.gov/show/NCT02508584 Completed Brigham and Women’s Hospital 2019-06-12
NCT02503293 A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push https://ClinicalTrials.gov/show/NCT02503293 Completed Octapharma 2017-12-11
NCT02479698 Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus https://ClinicalTrials.gov/show/NCT02479698 Recruiting M.D. Anderson Cancer Center 2020-07-31
NCT02435173 Study of Efficacy of CDZ173 in Patients With APDS/PASLI https://ClinicalTrials.gov/show/NCT02435173 Recruiting Novartis 2021-06-08
NCT02431247 A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects https://ClinicalTrials.gov/show/NCT02431247 Active, not recruiting Janssen Sciences Ireland UC 2017-03-02
NCT02403674 Comparison of MK-1439A and ATRIPLAâ„¢ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) https://ClinicalTrials.gov/show/NCT02403674 Active, not recruiting Merck Sharp & Dohme Corp. 2017-03-20
NCT02383797 Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox https://ClinicalTrials.gov/show/NCT02383797 Active, not recruiting Helsinki University Central Hospital 2019-10-31
NCT02358226 HIV & Drug Abuse Prevention for South African Men https://ClinicalTrials.gov/show/NCT02358226 Completed University of California, Los Angeles 2020-01-31
NCT02348177 Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB https://ClinicalTrials.gov/show/NCT02348177 Completed Drugs for Neglected Diseases 2016-12-31
NCT02345707 Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir https://ClinicalTrials.gov/show/NCT02345707 Completed ViiV Healthcare 2015-06-30
NCT02337595 Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT02337595 Completed Federal Research Institute of Pediatric Hematology, Oncology and Immunology 2015-03-31
NCT02337322 Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir https://ClinicalTrials.gov/show/NCT02337322 Active, not recruiting Hospital Clinic of Barcelona 2019-12-31
NCT02334943 Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment https://ClinicalTrials.gov/show/NCT02334943 Completed University Hospital, Montpellier 2015-03-31
NCT02282293 Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) https://ClinicalTrials.gov/show/NCT02282293 Completed University of California, San Francisco 2016-05-26
NCT02269917 Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants https://ClinicalTrials.gov/show/NCT02269917 Active, not recruiting Janssen R&D Ireland 2017-02-17
NCT02269163 Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% https://ClinicalTrials.gov/show/NCT02269163 Completed Prometic Biotherapeutics, Inc. 2019-01-11
NCT02266992 Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study https://ClinicalTrials.gov/show/NCT02266992 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2015-06-30
NCT02244450 Generalized Neonatal Screening of Severe Combined Immunodeficiencies https://ClinicalTrials.gov/show/NCT02244450 Completed Nantes University Hospital 2018-04-28
NCT02234492 The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT02234492 Completed Ottawa Heart Institute Research Corporation 2018-10-31
NCT02231710 Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases https://ClinicalTrials.gov/show/NCT02231710 Active, not recruiting Bellicum Pharmaceuticals 2015-07-16
NCT02196831 Tesamorelin Effects on Liver Fat and Histology in HIV https://ClinicalTrials.gov/show/NCT02196831 Completed Massachusetts General Hospital 2019-01-16
NCT02178592 Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection https://ClinicalTrials.gov/show/NCT02178592 Completed ViiV Healthcare 2017-11-02
NCT02149888 PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 https://ClinicalTrials.gov/show/NCT02149888 Completed St. Michael’s Hospital, Toronto 2016-06-30
NCT02128828 Effect of Cenicriviroc on HIV Neurocognitive Impairment https://ClinicalTrials.gov/show/NCT02128828 Completed University of Hawaii 2016-06-30
NCT02120352 A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects https://ClinicalTrials.gov/show/NCT02120352 Active, not recruiting ViiV Healthcare 2015-08-13
NCT02119390 Medication Adherence in Human Immunodeficiency Virus (HIV) https://ClinicalTrials.gov/show/NCT02119390 Completed St. Jude Children’s Research Hospital 2016-07-31
NCT02116179 DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients https://ClinicalTrials.gov/show/NCT02116179 Completed University of Delaware 2016-05-31
NCT02103439 An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients https://ClinicalTrials.gov/show/NCT02103439 Completed Biocad 2015-08-26
NCT02076178 Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) https://ClinicalTrials.gov/show/NCT02076178 Completed ViiV Healthcare 2015-05-15
NCT01313507 High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) https://ClinicalTrials.gov/show/NCT01313507 Completed Octapharma 2012-09-30
NCT01306019 Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) https://ClinicalTrials.gov/show/NCT01306019 Recruiting National Institutes of Health Clinical Center (CC) 2024-12-31
NCT01289951 Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis https://ClinicalTrials.gov/show/NCT01289951 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2011-06-30
NCT01289847 A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT01289847 Completed Bio Products Laboratory 2014-04-30
NCT03164967 Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16 https://ClinicalTrials.gov/show/NCT03164967 Recruiting ADMA Biologics, Inc. 2021-03-31
NCT03352219 Reality Check: An HIV Risk Reduction Serial Drama https://ClinicalTrials.gov/show/NCT03352219 Completed University of Pennsylvania 2017-03-31
NCT01998633 Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) https://ClinicalTrials.gov/show/NCT01998633 Completed Medical College of Wisconsin 2016-09-23
NCT01985373 Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml https://ClinicalTrials.gov/show/NCT01985373 Completed Sanquin Plasma Products BV 2015-03-31
NCT01968551 Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults https://ClinicalTrials.gov/show/NCT01968551 Completed Gilead Sciences 2015-07-21
NCT01967940 Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults https://ClinicalTrials.gov/show/NCT01967940 Completed Gilead Sciences 2015-05-21
NCT01966367 CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01966367 Active, not recruiting Columbia University 2022-01-31
NCT01963143 Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT01963143 Completed Bio Products Laboratory 2016-01-31
NCT01946906 The Rifaximin Study in CVID https://ClinicalTrials.gov/show/NCT01946906 Completed Oslo University Hospital 2014-12-31
NCT01939197 A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection https://ClinicalTrials.gov/show/NCT01939197 Completed AbbVie 2016-07-21
NCT01916759 Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda https://ClinicalTrials.gov/show/NCT01916759 Completed Emory University 2013-12-31
NCT01910402 A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) https://ClinicalTrials.gov/show/NCT01910402 Active, not recruiting ViiV Healthcare 2015-09-22
NCT01904994 Link4Health: A Combination Strategy for Linkage and Retention, Swaziland https://ClinicalTrials.gov/show/NCT01904994 Active, not recruiting Columbia University 2016-05-31
NCT01888484 Study of Octanorm Subcutaneous IG in Patients With PID https://ClinicalTrials.gov/show/NCT01888484 Active, not recruiting Octapharma 2020-07-31
NCT01884311 Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT01884311 Completed Bio Products Laboratory 2017-05-25
NCT01866267 Switching Undetectables to Selzentry https://ClinicalTrials.gov/show/NCT01866267 Completed St. Hope Foundation 2013-12-31
NCT01861106 Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations https://ClinicalTrials.gov/show/NCT01861106 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT01854775 Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children https://ClinicalTrials.gov/show/NCT01854775 Active, not recruiting Gilead Sciences 2020-11-30
NCT01852370 Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases https://ClinicalTrials.gov/show/NCT01852370 Enrolling by invitation University of Pittsburgh 2023-11-30
NCT01848483 Living Well Project for Persons With AIDS https://ClinicalTrials.gov/show/NCT01848483 Completed Emory University 2017-06-30
NCT01840722 Brief Intervention for Rural Women at High Risk for HIV/HCV https://ClinicalTrials.gov/show/NCT01840722 Completed University of Kentucky 2019-05-31
NCT01821781 Immune Disorder HSCT Protocol https://ClinicalTrials.gov/show/NCT01821781 Recruiting Washington University School of Medicine 2022-03-31
NCT01814800 Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) https://ClinicalTrials.gov/show/NCT01814800 Completed ADMA Biologics, Inc. 2014-12-31
NCT01812980 Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women https://ClinicalTrials.gov/show/NCT01812980 Completed University of Witwatersrand, South Africa 2013-07-31
NCT01783678 A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults https://ClinicalTrials.gov/show/NCT01783678 Completed Gilead Sciences 2014-04-30
NCT01766076 Atorvastatin for HAART Suboptimal Responders https://ClinicalTrials.gov/show/NCT01766076 Completed Makerere University 2014-02-28
NCT01727895 Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans https://ClinicalTrials.gov/show/NCT01727895 Completed Radboud University 2013-07-31
NCT01721109 Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents https://ClinicalTrials.gov/show/NCT01721109 Completed Gilead Sciences 2015-10-22
NCT01709084 A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment https://ClinicalTrials.gov/show/NCT01709084 Active, not recruiting Janssen-Cilag International NV 2015-10-22
NCT01705574 Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women https://ClinicalTrials.gov/show/NCT01705574 Completed Gilead Sciences 2015-02-09
NCT01683461 Efficacy of HIV Post-Test Support for ANC in South Africa https://ClinicalTrials.gov/show/NCT01683461 Completed University of North Carolina, Chapel Hill 2011-12-31
NCT01671501 Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients https://ClinicalTrials.gov/show/NCT01671501 Completed University of California, San Francisco 2016-08-31
NCT01667731 Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults https://ClinicalTrials.gov/show/NCT01667731 Completed Gilead Sciences 2013-11-30
NCT01652092 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies https://ClinicalTrials.gov/show/NCT01652092 Recruiting Masonic Cancer Center, University of Minnesota 2021-12-31
NCT01647191 Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China https://ClinicalTrials.gov/show/NCT01647191 Completed Shanghai Mental Health Center 2015-05-01
NCT01641809 Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine https://ClinicalTrials.gov/show/NCT01641809 Completed ViiV Healthcare 2013-10-10
NCT01590017 Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer https://ClinicalTrials.gov/show/NCT01590017 Completed AIDS Malignancy Consortium 2017-04-20
NCT01570595 Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV https://ClinicalTrials.gov/show/NCT01570595 Completed Georgetown University 2013-07-31
NCT01565850 D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults https://ClinicalTrials.gov/show/NCT01565850 Completed Gilead Sciences 2013-01-31
NCT01533259 Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01533259 Completed Gilead Sciences 2012-11-30
NCT01516970 Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) https://ClinicalTrials.gov/show/NCT01516970 Completed Janssen-Cilag G.m.b.H 2013-08-01
NCT01512888 Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants https://ClinicalTrials.gov/show/NCT01512888 Recruiting St. Jude Children’s Research Hospital 2025-08-31
NCT01502618 Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM) https://ClinicalTrials.gov/show/NCT01502618 Completed University of North Carolina, Chapel Hill 2011-01-31
NCT01497899 Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults https://ClinicalTrials.gov/show/NCT01497899 Completed Gilead Sciences 2012-10-17
NCT01495702 Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01495702 Completed Gilead Sciences 2013-11-30
NCT01490359 Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men https://ClinicalTrials.gov/show/NCT01490359 Completed University of Pennsylvania 2009-12-31
NCT01485796 Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD https://ClinicalTrials.gov/show/NCT01485796 Completed Shire 2013-01-01
NCT01479868 A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1 https://ClinicalTrials.gov/show/NCT01479868 Completed Janssen R&D Ireland 2013-08-31
NCT01475838 Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01475838 Completed Gilead Sciences 2013-11-30
NCT01465958 Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT01465958 Completed Grifols Therapeutics LLC 2013-10-31
NCT01461018 Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) https://ClinicalTrials.gov/show/NCT01461018 Completed CSL Behring 2014-07-31
NCT01458171 Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) https://ClinicalTrials.gov/show/NCT01458171 Completed CSL Behring 2012-02-29
NCT01455740 A Commitment Device for Medication Adherence Among HIV Patients https://ClinicalTrials.gov/show/NCT01455740 Completed National Bureau of Economic Research, Inc. 2013-06-30
NCT01449006 A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) https://ClinicalTrials.gov/show/NCT01449006 Completed St Vincent’s Hospital, Sydney 2014-09-30
NCT01448707 A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment https://ClinicalTrials.gov/show/NCT01448707 Completed Janssen-Cilag International NV 2014-06-11
NCT01440569 Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults https://ClinicalTrials.gov/show/NCT01440569 Completed Gilead Sciences 2012-08-31
NCT01433185 Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV https://ClinicalTrials.gov/show/NCT01433185 Completed University of Washington 2013-07-31
NCT01425073 Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya https://ClinicalTrials.gov/show/NCT01425073 Completed University of Washington 2013-10-31
NCT01422330 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01422330 Completed Janssen R&D Ireland 2013-11-30
NCT01420627 EZN-2279 in Patients With ADA-SCID https://ClinicalTrials.gov/show/NCT01420627 Completed Leadiant Biosciences, Inc. 2018-04-10
NCT01412385 Immune Globulin Subcutaenous (Human), 20% https://ClinicalTrials.gov/show/NCT01412385 Completed Shire 2014-05-13
NCT01406470 Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SNâ„¢ in Subjects With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT01406470 Completed Green Cross Corporation 2013-07-31
NCT01403792 A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects https://ClinicalTrials.gov/show/NCT01403792 Completed University of Surrey 2011-11-30
NCT01401335 HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth https://ClinicalTrials.gov/show/NCT01401335 Completed Stanford University 2010-12-31
NCT01391013 A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01391013 Completed Janssen-Cilag S.p.A. 2011-04-30
NCT01384734 HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections https://ClinicalTrials.gov/show/NCT01384734 Completed ViiV Healthcare 2013-02-18
NCT01369056 HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence https://ClinicalTrials.gov/show/NCT01369056 Completed University of Tartu 2011-12-31
NCT01363011 Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment https://ClinicalTrials.gov/show/NCT01363011 Completed Gilead Sciences 2013-01-31
NCT04286815 Gene Therapy for X Linked Severe Combined Immunodeficiency https://ClinicalTrials.gov/show/NCT04286815 Recruiting Children’s Hospital of Chongqing Medical University 2023-05-01
NCT04232085 Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide https://ClinicalTrials.gov/show/NCT04232085 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2024-12-31
NCT04223804 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 https://ClinicalTrials.gov/show/NCT04223804 Recruiting AbbVie 2021-11-20
NCT04192487 Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea https://ClinicalTrials.gov/show/NCT04192487 Recruiting Napo Pharmaceuticals, Inc. 2020-04-30
NCT04140539 A Clinical Study to Enable Process Validation of Commercial Grade OTL-101 https://ClinicalTrials.gov/show/NCT04140539 Recruiting Orchard Therapeutics 2020-08-30
NCT04135937 Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) https://ClinicalTrials.gov/show/NCT04135937 Recruiting VA Office of Research and Development 2021-07-01
NCT04122404 POC Strategies to Improve TB Care in Advanced HIV Disease https://ClinicalTrials.gov/show/NCT04122404 Recruiting University of Southern Denmark 2021-08-15
NCT04069546 The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency https://ClinicalTrials.gov/show/NCT04069546 Recruiting Capital Medical University 2020-02-01
NCT04003701 Using a Humanoid Robot to Distract Children With Cancer or Chronic Immune Deficiency Undergoing Painful Procedures https://ClinicalTrials.gov/show/NCT04003701 Recruiting Vrije Universiteit Brussel 2020-12-31
NCT03996538 Vaccination Efficacy With Metformin in Older Adults https://ClinicalTrials.gov/show/NCT03996538 Active, not recruiting UConn Health 2021-03-31
NCT03988426 Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT03988426 Completed Octapharma 2018-01-26
NCT03968211 Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency https://ClinicalTrials.gov/show/NCT03968211 Recruiting University of Virginia 2021-06-30
NCT03939533 Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT03939533 Recruiting Octapharma 2021-03-31
NCT03907241 Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases, Including (But Not Limited to) Those Who Have Completed the SCGAM-01 Trial https://ClinicalTrials.gov/show/NCT03907241 Completed Octapharma 2019-08-16
NCT03899480 Adoptive Transfer of Haploidentical NK Cells and N-803 https://ClinicalTrials.gov/show/NCT03899480 Recruiting University of Minnesota 2020-09-01
NCT03896932 Minipooled-IVIG in Primary Immunodeficiency Disease https://ClinicalTrials.gov/show/NCT03896932 Completed Assiut University 2020-05-01
NCT03836690 Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03836690 Recruiting University College, London 2022-07-01
NCT03835312 Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM https://ClinicalTrials.gov/show/NCT03835312 Recruiting Children’s Hospital of Fudan University 2024-12-31
NCT03827278 Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy https://ClinicalTrials.gov/show/NCT03827278 Recruiting Guangxi Medical University 2021-12-30
NCT01218438 Phase 2/3 Study of IGSC, 20% in PIDD https://ClinicalTrials.gov/show/NCT01218438 Completed Shire 2015-03-31
NCT03783130 Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults https://ClinicalTrials.gov/show/NCT03783130 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-02-29
NCT03765632 Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID https://ClinicalTrials.gov/show/NCT03765632 Recruiting Great Ormond Street Hospital for Children NHS Foundation Trust 2021-07-31
NCT03746600 Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS https://ClinicalTrials.gov/show/NCT03746600 Recruiting University of Georgia 2022-07-31
NCT03730129 Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig https://ClinicalTrials.gov/show/NCT03730129 Recruiting Rochester General Hospital 2020-11-30
NCT03677557 Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment https://ClinicalTrials.gov/show/NCT03677557 Recruiting Ottawa Hospital Research Institute 2021-08-31
NCT03663933 Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation https://ClinicalTrials.gov/show/NCT03663933 Recruiting National Institutes of Health Clinical Center (CC) 2023-05-27
NCT03645460 Gene Transfer for ADA-SCID Using an Improved Lentiviral Vector (TYF-ADA) https://ClinicalTrials.gov/show/NCT03645460 Recruiting Shenzhen Geno-Immune Medical Institute 2020-12-31
NCT03615183 A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) https://ClinicalTrials.gov/show/NCT03615183 Completed Merck Sharp & Dohme Corp. 2019-09-26
NCT03601286 Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency https://ClinicalTrials.gov/show/NCT03601286 Recruiting Great Ormond Street Hospital for Children NHS Foundation Trust 2024-12-31
NCT03597594 Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) https://ClinicalTrials.gov/show/NCT03597594 Recruiting St. Jude Children’s Research Hospital 2027-07-01
NCT03563742 A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection https://ClinicalTrials.gov/show/NCT03563742 Recruiting Johnson & Johnson Pte Ltd 2021-12-15
NCT03557463 Testing a Novel Dairy Protein to Counteract Immunosenescence https://ClinicalTrials.gov/show/NCT03557463 Completed University of California, Davis 2017-08-01
NCT03538899 Autologous Gene Therapy for Artemis-Deficient SCID https://ClinicalTrials.gov/show/NCT03538899 Recruiting University of California, San Francisco 2038-06-30
NCT03529409 Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa https://ClinicalTrials.gov/show/NCT03529409 Active, not recruiting University of Maryland, College Park 2021-01-31
NCT03513328 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation https://ClinicalTrials.gov/show/NCT03513328 Recruiting University of Florida 2021-06-30
NCT03427593 Severe PID With Lymphoproliferation and Neutropenia https://ClinicalTrials.gov/show/NCT03427593 Completed University Hospital, Strasbourg, France 2018-03-13
NCT01227590 Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir) https://ClinicalTrials.gov/show/NCT01227590 Completed University of California, San Francisco 2011-02-28
NCT01209117 A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435 https://ClinicalTrials.gov/show/NCT01209117 Completed ViiV Healthcare 2011-01-31
NCT01199939 A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients https://ClinicalTrials.gov/show/NCT01199939 Completed Tibotec, Inc 2012-10-31
NCT01199705 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) https://ClinicalTrials.gov/show/NCT01199705 Completed CSL Behring 2011-08-31
NCT01186575 Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision https://ClinicalTrials.gov/show/NCT01186575 Completed University of Washington 2011-03-31
NCT01175213 Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID https://ClinicalTrials.gov/show/NCT01175213 Completed Shire 2013-08-06
NCT01171495 Impact of Nutrition Intervention on HIV/AIDS Infected Patients https://ClinicalTrials.gov/show/NCT01171495 Completed Caribbean Health Research Council 2009-08-31
NCT01131858 Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT01131858 Completed Karolinska University Hospital 2011-06-30
NCT01129544 Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector https://ClinicalTrials.gov/show/NCT01129544 Active, not recruiting Boston Children’s Hospital 2022-03-31
NCT01093417 Study of Vitamin D and Effect on Heart Disease and Insulin Resistance https://ClinicalTrials.gov/show/NCT01093417 Completed University Hospitals Cleveland Medical Center 2010-10-31
NCT01090102 Mesalamine to Reduce T Cell Activation in HIV Infection https://ClinicalTrials.gov/show/NCT01090102 Completed University of California, San Francisco 2012-12-31
NCT01086878 Safety of Cotrimoxazole in HIV- and HAART-exposed Infants https://ClinicalTrials.gov/show/NCT01086878 Completed Harvard School of Public Health 2010-10-31
NCT01077960 Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome https://ClinicalTrials.gov/show/NCT01077960 Completed EMD Serono 2006-01-31
NCT01077310 Alcohol Pharmacotherapy for HIV+ Prisoners https://ClinicalTrials.gov/show/NCT01077310 Completed Yale University 2015-08-31
NCT01038076 Medications for Chronic HIV: Education and Collaboration https://ClinicalTrials.gov/show/NCT01038076 Completed Boston University 2013-06-30
NCT01032408 Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection https://ClinicalTrials.gov/show/NCT01032408 Completed Chiltern Pesquisa Clinica Ltda 2011-09-30
NCT01012323 A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT01012323 Completed Octapharma 2012-06-30
NCT00988039 Europe-Africa Research Network for Evaluation of Second-line Therapy https://ClinicalTrials.gov/show/NCT00988039 Completed Medical Research Council 2014-01-31
NCT00985543 Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. https://ClinicalTrials.gov/show/NCT00985543 Completed Kirby Institute 2010-01-31
NCT00972699 Mentor Mothers: A Sustainable Family Intervention in South African Townships https://ClinicalTrials.gov/show/NCT00972699 Completed University of California, Los Angeles 2011-12-31
NCT00966160 CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes https://ClinicalTrials.gov/show/NCT00966160 Completed University of Cologne 2008-12-31
NCT00947947 Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program https://ClinicalTrials.gov/show/NCT00947947 Completed University of North Carolina, Chapel Hill 2012-05-31
NCT00923364 Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC https://ClinicalTrials.gov/show/NCT00923364 Completed National Institutes of Health Clinical Center (CC) 2014-06-12
NCT00919854 A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children https://ClinicalTrials.gov/show/NCT00919854 Completed Tibotec Pharmaceuticals, Ireland 2010-08-31
NCT00917904 An Expanded Safety Study of Dapivirine Gel 4789 in Africa https://ClinicalTrials.gov/show/NCT00917904 Completed International Partnership for Microbicides, Inc. 2010-09-30
NCT00917891 An Expanded Safety Study of Dapivirine Gel 4759 in Africa https://ClinicalTrials.gov/show/NCT00917891 Completed International Partnership for Microbicides, Inc. 2011-01-31
NCT00908284 Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV https://ClinicalTrials.gov/show/NCT00908284 Completed University of Miami 2015-11-30
NCT00903682 A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT00903682 Completed Janssen-Cilag International NV 2010-02-28
NCT00896051 TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients https://ClinicalTrials.gov/show/NCT00896051 Completed Janssen R&D Ireland 2012-04-30
NCT03330795 Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT03330795 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2023-11-30
NCT00838162 A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients https://ClinicalTrials.gov/show/NCT00838162 Completed Tibotec Pharmaceuticals, Ireland 2009-08-31
NCT00814879 Pilot Study of a Raltegravir Based NRTI Sparing Regimen https://ClinicalTrials.gov/show/NCT00814879 Completed Yale University 2013-05-31
NCT00814320 Gammagard Liquid and rHuPH20 in PID https://ClinicalTrials.gov/show/NCT00814320 Completed Shire 2010-11-11
NCT01550341 HIV, Buprenorphine, and the Criminal Justice System https://ClinicalTrials.gov/show/NCT01550341 Completed Yale University 2015-11-30
NCT01385241 Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women https://ClinicalTrials.gov/show/NCT01385241 Completed Duke University 2014-01-31
NCT02823847 Non Invasive Oral Cancer Screening Among HIV Infected Individuals https://ClinicalTrials.gov/show/NCT02823847 Active, not recruiting M.D. Anderson Cancer Center 2020-07-31
NCT02579967 Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT02579967 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-21
NCT02583464 Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. https://ClinicalTrials.gov/show/NCT02583464 Completed Laboratorio Elea Phoenix S.A. 2014-10-31
NCT02396979 Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia https://ClinicalTrials.gov/show/NCT02396979 Completed Yale University 2014-12-31
NCT02180763 Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps https://ClinicalTrials.gov/show/NCT02180763 Completed Octapharma 2016-08-28
NCT03961009 Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID) https://ClinicalTrials.gov/show/NCT03961009 Recruiting Kedrion S.p.A. 2021-02-16
NCT00794508 MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID https://ClinicalTrials.gov/show/NCT00794508 Completed University of California, Los Angeles 2014-12-31
NCT00782106 Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously https://ClinicalTrials.gov/show/NCT00782106 Completed Shire 2007-11-01
NCT00751621 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) https://ClinicalTrials.gov/show/NCT00751621 Completed CSL Behring 2011-12-31
NCT00744692 Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders https://ClinicalTrials.gov/show/NCT00744692 Completed Duke University 2012-12-31
NCT00719680 Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) https://ClinicalTrials.gov/show/NCT00719680 Completed CSL Behring 2010-06-30
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) https://ClinicalTrials.gov/show/NCT00711009 Completed Abbott 2009-11-30
NCT00698334 Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis https://ClinicalTrials.gov/show/NCT00698334 Completed All India Institute of Medical Sciences, New Delhi 2010-09-30
NCT00692926 Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells https://ClinicalTrials.gov/show/NCT00692926 Completed Duke University 2012-07-31
NCT00680446 Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT00680446 Completed CSL Limited 2013-05-31
NCT00634569 Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects https://ClinicalTrials.gov/show/NCT00634569 Completed Grifols Biologicals, LLC 2011-03-31
NCT00602758 Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV https://ClinicalTrials.gov/show/NCT00602758 Completed University of Missouri, Kansas City 2009-08-31
NCT00599781 Gene Therapy for ADA-SCID https://ClinicalTrials.gov/show/NCT00599781 Completed IRCCS San Raffaele 2006-07-31
NCT00598481 ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID https://ClinicalTrials.gov/show/NCT00598481 Completed Orchard Therapeutics 2011-07-10
NCT00579124 CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion https://ClinicalTrials.gov/show/NCT00579124 Active, not recruiting Children’s Hospital of Philadelphia 2021-12-31
NCT00553098 Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders https://ClinicalTrials.gov/show/NCT00553098 Completed Fred Hutchinson Cancer Research Center 2015-03-31
NCT00551330 Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) https://ClinicalTrials.gov/show/NCT00551330 Completed Merck Sharp & Dohme Corp. 2010-02-28
NCT00546871 Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects https://ClinicalTrials.gov/show/NCT00546871 Completed Shire 2009-07-01
NCT00542997 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy https://ClinicalTrials.gov/show/NCT00542997 Completed CSL Behring 2009-08-31
NCT00538915 Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) https://ClinicalTrials.gov/show/NCT00538915 Completed Biotest Pharmaceuticals Corporation 2009-07-31
NCT00524368 A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) https://ClinicalTrials.gov/show/NCT00524368 Completed Tibotec Pharmaceuticals, Ireland 2009-08-31
NCT00523211 Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) https://ClinicalTrials.gov/show/NCT00523211 Completed Merck Sharp & Dohme Corp. 2009-06-30
NCT00520494 Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT00520494 Completed CSL Behring 2008-10-31
NCT00517803 Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies https://ClinicalTrials.gov/show/NCT00517803 Completed Lawson Health Research Institute 2009-03-02
NCT00502827 Smoking Cessation for HIV/AIDS Patients https://ClinicalTrials.gov/show/NCT00502827 Completed M.D. Anderson Cancer Center 2015-04-30
NCT00478231 Multicenter, Safety Study Of Maraviroc https://ClinicalTrials.gov/show/NCT00478231 Completed ViiV Healthcare 2010-08-31
NCT00474370 Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) https://ClinicalTrials.gov/show/NCT00474370 Completed Merck Sharp & Dohme Corp. 2009-08-31
NCT00468273 A Clinical Study of Intravenous Immunoglobulin https://ClinicalTrials.gov/show/NCT00468273 Completed FFF Enterprises 2009-05-31
NCT00458302 Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir https://ClinicalTrials.gov/show/NCT00458302 Completed Janssen-Cilag International NV 2009-02-28
NCT00443378 Computer Assisted Rx Education for HIV-Positives: CARE+ https://ClinicalTrials.gov/show/NCT00443378 Completed University of Washington 2007-06-30
NCT00441688 Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT00441688 Completed ViiV Healthcare 2007-06-01
NCT00426517 Donor Stem Cell Transplantation for Congenital Immunodeficiencies https://ClinicalTrials.gov/show/NCT00426517 Completed National Institutes of Health Clinical Center (CC) 2019-11-01
NCT00419341 Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy https://ClinicalTrials.gov/show/NCT00419341 Completed CSL Behring 2008-10-31
NCT00405184 Ig NextGen 10% in Patients With Primary Immune Deficiency (PID) https://ClinicalTrials.gov/show/NCT00405184 Completed CSL Limited 2008-07-31
NCT00391131 Subcutaneous Ig NextGen 16% in PID Patients https://ClinicalTrials.gov/show/NCT00391131 Completed CSL Limited 2009-10-31
NCT00389324 A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT00389324 Completed Grifols Therapeutics LLC 2008-08-31
NCT00344591 Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison https://ClinicalTrials.gov/show/NCT00344591 Completed University of California, San Francisco 2009-06-30
NCT00381524 HIV Prevention in the Primary Care Setting https://ClinicalTrials.gov/show/NCT00381524 Completed University of Alabama at Birmingham 2007-06-30
NCT00381212 A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. https://ClinicalTrials.gov/show/NCT00381212 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2008-02-29
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects https://ClinicalTrials.gov/show/NCT00358917 Completed Abbott 2008-11-30
NCT00358657 Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders https://ClinicalTrials.gov/show/NCT00358657 Active, not recruiting Fred Hutchinson Cancer Research Center 2023-12-01
NCT00337467 Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression https://ClinicalTrials.gov/show/NCT00337467 Completed Bristol-Myers Squibb 2008-05-31
NCT00335322 ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens https://ClinicalTrials.gov/show/NCT00335322 Completed Kirby Institute 2011-03-31
NCT00325611 Multidisciplinary Inpatient Palliative Care Intervention https://ClinicalTrials.gov/show/NCT00325611 Completed Kaiser Permanente NA
NCT00325585 HIV Prevention Intervention for Couples https://ClinicalTrials.gov/show/NCT00325585 Completed National Development and Research Institutes, Inc. 2007-12-31
NCT00322556 Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) https://ClinicalTrials.gov/show/NCT00322556 Completed CSL Behring 2008-04-30
NCT00296153 Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment https://ClinicalTrials.gov/show/NCT00296153 Completed Pronova BioPharma 2006-11-30
NCT00295971 Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease https://ClinicalTrials.gov/show/NCT00295971 Completed University of California, San Francisco 2011-12-31
NCT00294918 An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome https://ClinicalTrials.gov/show/NCT00294918 Completed EMD Serono 2003-02-28
NCT00294164 Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) https://ClinicalTrials.gov/show/NCT00294164 Completed EMD Serono 2002-05-31
NCT00278954 Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. https://ClinicalTrials.gov/show/NCT00278954 Completed Bio Products Laboratory 2007-11-30
NCT00273988 Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults https://ClinicalTrials.gov/show/NCT00273988 Completed Boehringer Ingelheim 2003-10-31
NCT00272220 Longitudinal Study of HAART, Social Networks, & Adherence https://ClinicalTrials.gov/show/NCT00272220 Completed University of Washington NA
NCT00270283 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy https://ClinicalTrials.gov/show/NCT00270283 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00270270 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy https://ClinicalTrials.gov/show/NCT00270270 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00270010 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease https://ClinicalTrials.gov/show/NCT00270010 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00269945 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease https://ClinicalTrials.gov/show/NCT00269945 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00263237 STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency https://ClinicalTrials.gov/show/NCT00263237 Completed National Institutes of Health Clinical Center (CC) NA
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects https://ClinicalTrials.gov/show/NCT00262522 Completed Abbott 2008-07-31
NCT00241202 The Efficacy of the HIV/AIDS Symptom Management Manual https://ClinicalTrials.gov/show/NCT00241202 Completed University of California, San Francisco 2006-12-31
NCT00228852 IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency https://ClinicalTrials.gov/show/NCT00228852 Completed Emory University NA
NCT00220766 Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients https://ClinicalTrials.gov/show/NCT00220766 Completed Grifols Therapeutics LLC 2002-08-31
NCT00176865 Stem Cell Transplant for Immunologic or Histiocytic Disorders https://ClinicalTrials.gov/show/NCT00176865 Completed Masonic Cancer Center, University of Minnesota 2012-08-31
NCT00168025 Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) https://ClinicalTrials.gov/show/NCT00168025 Completed CSL Behring NA
NCT00168012 Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) https://ClinicalTrials.gov/show/NCT00168012 Completed CSL Behring NA
NCT00161993 Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) https://ClinicalTrials.gov/show/NCT00161993 Completed Shire NA
NCT00157079 Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders https://ClinicalTrials.gov/show/NCT00157079 Completed Shire 2003-12-16
NCT00152100 Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00152100 Completed St. Jude Children’s Research Hospital 2007-08-31
NCT00144183 A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) https://ClinicalTrials.gov/show/NCT00144183 Completed Boehringer Ingelheim 2007-01-31
NCT00144157 Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV https://ClinicalTrials.gov/show/NCT00144157 Completed Boehringer Ingelheim 2006-07-31
NCT00128830 A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study https://ClinicalTrials.gov/show/NCT00128830 Completed Tibotec Pharmaceuticals, Ireland 2008-08-31
NCT00110305 A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines https://ClinicalTrials.gov/show/NCT00110305 Completed Tibotec Pharmaceuticals, Ireland 2011-12-31
NCT00105157 Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) https://ClinicalTrials.gov/show/NCT00105157 Completed Merck Sharp & Dohme Corp. 2006-10-31
NCT00100048 A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) https://ClinicalTrials.gov/show/NCT00100048 Completed Merck Sharp & Dohme Corp. 2006-10-31
NCT00082628 Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients https://ClinicalTrials.gov/show/NCT00082628 Completed EMD Serono 2005-09-28
NCT00064740 Relaxation Response With Acupuncture for HIV Patients https://ClinicalTrials.gov/show/NCT00064740 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00055185 Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00055185 Completed Progenics Pharmaceuticals, Inc. NA
NCT00000638 Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection https://ClinicalTrials.gov/show/NCT00000638 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001968 Once-Daily Drug Regimen for HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00001968 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001763 Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection https://ClinicalTrials.gov/show/NCT00001763 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001646 Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis https://ClinicalTrials.gov/show/NCT00001646 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001538 Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers https://ClinicalTrials.gov/show/NCT00001538 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001443 A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection https://ClinicalTrials.gov/show/NCT00001443 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001438 A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes https://ClinicalTrials.gov/show/NCT00001438 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001267 A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2’,3’-Dideoxyinosine https://ClinicalTrials.gov/show/NCT00001267 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001542 Fluconazole Prophylaxis of Thrush in AIDS https://ClinicalTrials.gov/show/NCT00001542 Completed National Institutes of Health Clinical Center (CC) NA
NCT00033852 Treatment of Depression With Massage in HIV https://ClinicalTrials.gov/show/NCT00033852 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00033176 Immune Restoration by Lipoic Acid in AIDS https://ClinicalTrials.gov/show/NCT00033176 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00032721 The Use of Reiki for Patients With Advanced AIDS https://ClinicalTrials.gov/show/NCT00032721 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00028236 Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) https://ClinicalTrials.gov/show/NCT00028236 Completed National Institutes of Health Clinical Center (CC) 2011-07-25
NCT00023504 Antibody Production in Immune Disorders https://ClinicalTrials.gov/show/NCT00023504 Recruiting National Institutes of Health Clinical Center (CC) 2026-09-19
NCT00002408 A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients https://ClinicalTrials.gov/show/NCT00002408 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002272 An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies https://ClinicalTrials.gov/show/NCT00002272 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002268 A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria https://ClinicalTrials.gov/show/NCT00002268 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002255 An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) https://ClinicalTrials.gov/show/NCT00002255 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002254 A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3’-Deoxy-3’-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) https://ClinicalTrials.gov/show/NCT00002254 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002253 A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either “Responders” or “Non-Responders” in a Prior Placebo-Controlled Double-Blind Sandostatin Study. https://ClinicalTrials.gov/show/NCT00002253 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002252 A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea https://ClinicalTrials.gov/show/NCT00002252 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002186 Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS) https://ClinicalTrials.gov/show/NCT00002186 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002112 Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00002112 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002095 A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus https://ClinicalTrials.gov/show/NCT00002095 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002090 An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) https://ClinicalTrials.gov/show/NCT00002090 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002088 Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial https://ClinicalTrials.gov/show/NCT00002088 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002082 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study https://ClinicalTrials.gov/show/NCT00002082 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002074 Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00002074 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002044 A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases https://ClinicalTrials.gov/show/NCT00002044 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent https://ClinicalTrials.gov/show/NCT00002029 Completed Abbott NA
NCT00002028 A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2’,3’-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) https://ClinicalTrials.gov/show/NCT00002028 Completed Bristol-Myers Squibb NA
NCT00002021 An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies https://ClinicalTrials.gov/show/NCT00002021 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002019 Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00002019 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002016 A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis https://ClinicalTrials.gov/show/NCT00002016 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002002 A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00002002 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002001 The Antiviral Efficacy of Concurrent Zidovudine and 2’,3’-Dideoxyinosine or 2’,3’-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease https://ClinicalTrials.gov/show/NCT00002001 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001998 Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC) https://ClinicalTrials.gov/show/NCT00001998 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001994 A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine https://ClinicalTrials.gov/show/NCT00001994 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001386 Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection https://ClinicalTrials.gov/show/NCT00001386 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000959 Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection https://ClinicalTrials.gov/show/NCT00000959 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000958 A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only) https://ClinicalTrials.gov/show/NCT00000958 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000955 Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection https://ClinicalTrials.gov/show/NCT00000955 Completed National Institute of Allergy and Infectious Diseases (NIAID) 1992-12-31
NCT00000733 Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients https://ClinicalTrials.gov/show/NCT00000733 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000726 Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00000726 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000701 A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC) https://ClinicalTrials.gov/show/NCT00000701 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000700 A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP https://ClinicalTrials.gov/show/NCT00000700 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000692 Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex https://ClinicalTrials.gov/show/NCT00000692 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000684 Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals https://ClinicalTrials.gov/show/NCT00000684 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000683 A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus https://ClinicalTrials.gov/show/NCT00000683 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000636 Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection https://ClinicalTrials.gov/show/NCT00000636 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000627 Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome https://ClinicalTrials.gov/show/NCT00000627 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00018018 Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency https://ClinicalTrials.gov/show/NCT00018018 Completed National Institutes of Health Clinical Center (CC) NA
NCT00008450 Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00008450 Completed Fred Hutchinson Cancer Research Center 2011-10-25
NCT00006131 Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster https://ClinicalTrials.gov/show/NCT00006131 Completed National Center for Research Resources (NCRR) NA
NCT00004794 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis https://ClinicalTrials.gov/show/NCT00004794 Completed Office of Rare Diseases (ORD) NA
NCT00004695 Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency https://ClinicalTrials.gov/show/NCT00004695 Completed FDA Office of Orphan Products Development NA
NCT00004664 Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting https://ClinicalTrials.gov/show/NCT00004664 Completed Office of Rare Diseases (ORD) NA
NCT00001647 White Blood Cell Infusions to Treat HIV Infection https://ClinicalTrials.gov/show/NCT00001647 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001535 Twins Study of Gene Therapy for HIV Infection https://ClinicalTrials.gov/show/NCT00001535 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001524 Thalidomide to Treat Oral Lesions in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00001524 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001475 Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist https://ClinicalTrials.gov/show/NCT00001475 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001409 Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications https://ClinicalTrials.gov/show/NCT00001409 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001354 Interleukin-2 Therapy for HIV Infection - Supplemental Procedures https://ClinicalTrials.gov/show/NCT00001354 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000593 Viral Activation Transfusion Study (VATS) https://ClinicalTrials.gov/show/NCT00000593 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000590 Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) https://ClinicalTrials.gov/show/NCT00000590 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000587 Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection https://ClinicalTrials.gov/show/NCT00000587 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000134 Studies of the Ocular Complications of AIDS (SOCA)–Cytomegalovirus Retinitis Retreatment Trial (CRRT) https://ClinicalTrials.gov/show/NCT00000134 Completed Johns Hopkins Bloomberg School of Public Health 1995-03-31
NCT00000118 Ganciclovir Implant Study for Cytomegalovirus Retinitis https://ClinicalTrials.gov/show/NCT00000118 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00055172 Genetic Basis of Immunodeficiency https://ClinicalTrials.gov/show/NCT00055172 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04408950 Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects https://ClinicalTrials.gov/show/NCT04408950 Recruiting National Institutes of Health Clinical Center (CC) 2030-05-01
NCT03394053 The Mechanistic Biology of Primary Immunodeficiency Disorders https://ClinicalTrials.gov/show/NCT03394053 Recruiting National Institutes of Health Clinical Center (CC) 2029-12-31
NCT03374566 Immunodeficiency for Severe Epstein-Barr Virus Infection https://ClinicalTrials.gov/show/NCT03374566 Recruiting Children’s Hospital of Fudan University 2022-11-30
NCT03369301 The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency https://ClinicalTrials.gov/show/NCT03369301 Recruiting Octapharma 2021-09-25
NCT03339778 The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations https://ClinicalTrials.gov/show/NCT03339778 Completed IMMUNOe Research Centers 2016-11-30
NCT03335605 Improving the Diagnosis of Common Variable Immune Deficiency https://ClinicalTrials.gov/show/NCT03335605 Recruiting University of California, Los Angeles 2019-12-31
NCT03310515 Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT03310515 Completed ViiV Healthcare 2018-12-31
NCT03300830 Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease https://ClinicalTrials.gov/show/NCT03300830 Recruiting National Institutes of Health Clinical Center (CC) 2037-06-07
NCT03250845 Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder https://ClinicalTrials.gov/show/NCT03250845 Completed Universitaire Ziekenhuizen Leuven 2017-10-31
NCT03188419 Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide https://ClinicalTrials.gov/show/NCT03188419 Completed National Institutes of Health Clinical Center (CC) 2019-12-29
NCT03148028 Immunological Characteristics of Patients With PID and IBD https://ClinicalTrials.gov/show/NCT03148028 Recruiting Sheba Medical Center 2020-06-01
NCT03054181 Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO) https://ClinicalTrials.gov/show/NCT03054181 Recruiting GWT-TUD GmbH 2019-12-31
NCT02969161 Safe Generations Plus: Swaziland PMTCT LTF Study https://ClinicalTrials.gov/show/NCT02969161 Completed Columbia University 2017-05-31
NCT02909244 Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02909244 Completed Imagine Institute 2017-02-28
NCT02804724 Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study https://ClinicalTrials.gov/show/NCT02804724 Completed University of Aberdeen 2015-08-31
NCT02735824 Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT02735824 Recruiting University Children’s Hospital, Zurich 2022-01-31
NCT02593188 Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) https://ClinicalTrials.gov/show/NCT02593188 Active, not recruiting Shire 2021-10-30
NCT02590328 Neonatal Screening of Severe Combined Immunodeficiencies https://ClinicalTrials.gov/show/NCT02590328 Recruiting Children’s Hospital of Fudan University 2020-12-31
NCT00895271 Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders https://ClinicalTrials.gov/show/NCT00895271 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT00246857 Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death https://ClinicalTrials.gov/show/NCT00246857 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001788 Genetic Basis of Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT00001788 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001244 Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes https://ClinicalTrials.gov/show/NCT00001244 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02554630 Novel Mechanisms and Approaches to Treat Neonatal Sepsis https://ClinicalTrials.gov/show/NCT02554630 Recruiting University of Florida 2020-10-31
NCT02542228 Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency Disease https://ClinicalTrials.gov/show/NCT02542228 Completed University of South Florida 2016-01-31
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT02542020 Recruiting Oswaldo Cruz Foundation 2020-05-31
NCT02532348 Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection https://ClinicalTrials.gov/show/NCT02532348 Completed Centre Hospitalier Universitaire de Saint Etienne 2014-09-30
NCT02526940 Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men https://ClinicalTrials.gov/show/NCT02526940 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-08-31
NCT02417740 Natural History of Noncirrhotic Portal Hypertension https://ClinicalTrials.gov/show/NCT02417740 Recruiting National Institutes of Health Clinical Center (CC) 2029-09-04
NCT02027714 Enhanced HIV Prevention in Couples: Feasibility Study #1 https://ClinicalTrials.gov/show/NCT02027714 Completed Columbia University 2014-05-31
NCT02322827 Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART https://ClinicalTrials.gov/show/NCT02322827 Completed Triple O Research Institute PA 2016-10-31
NCT02303093 Non-Interventional Study on the Tolerability and Efficacy of IVIG https://ClinicalTrials.gov/show/NCT02303093 Recruiting Octapharma 2019-12-31
NCT02027519 Enhanced HIV Prevention in Couples: Feasibility Study #3 https://ClinicalTrials.gov/show/NCT02027519 Completed Columbia University 2014-05-31
NCT02027480 Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study https://ClinicalTrials.gov/show/NCT02027480 Completed Columbia University 2015-10-31
NCT02027441 Enhanced Prevention in Couples: Feasibility Study #2 https://ClinicalTrials.gov/show/NCT02027441 Completed Columbia University 2013-08-31
NCT02191215 Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS https://ClinicalTrials.gov/show/NCT02191215 Completed Boehringer Ingelheim 2004-05-31
NCT02176239 Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting https://ClinicalTrials.gov/show/NCT02176239 Completed BriovaRx Infusion Services 2019-08-31
NCT02113865 Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients https://ClinicalTrials.gov/show/NCT02113865 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2014-10-31
NCT02043769 Pediatric Enhanced Surveillance Study https://ClinicalTrials.gov/show/NCT02043769 Completed Columbia University 2015-10-31
NCT01997346 Multi-level Determinants of Starting ART Late: Aim 2 https://ClinicalTrials.gov/show/NCT01997346 Completed Columbia University 2011-12-31
NCT01976715 Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT01976715 Recruiting National Institutes of Health Clinical Center (CC) 2025-08-01
NCT01953016 Participation in a Research Registry for Immune Disorders https://ClinicalTrials.gov/show/NCT01953016 Recruiting National Institutes of Health Clinical Center (CC) 2021-05-01
NCT01859754 Octagam 5% Versus Comparator Post Marketing Trial https://ClinicalTrials.gov/show/NCT01859754 Completed Octapharma 2019-05-22
NCT01849393 Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents https://ClinicalTrials.gov/show/NCT01849393 Completed St. Jude Children’s Research Hospital 2013-12-31
NCT01748968 Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence https://ClinicalTrials.gov/show/NCT01748968 Completed VA Eastern Colorado Health Care System 2015-09-30
NCT01741844 A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence https://ClinicalTrials.gov/show/NCT01741844 Completed Janssen Korea, Ltd., Korea 2014-07-31
NCT01741831 A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista https://ClinicalTrials.gov/show/NCT01741831 Completed Janssen Korea, Ltd., Korea 2016-10-31
NCT01662336 Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program https://ClinicalTrials.gov/show/NCT01662336 Completed AbbVie 2016-06-30
NCT01616823 Fetal HIV Transmission Risk and Duration of Membrane Rupture https://ClinicalTrials.gov/show/NCT01616823 Completed St. Michael’s Hospital, Toronto 2009-12-31
NCT01615601 An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01615601 Completed Janssen Inc. 2013-04-30
NCT01541085 An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART https://ClinicalTrials.gov/show/NCT01541085 Completed Janssen-Cilag S.p.A. 2013-06-30
NCT01450059 Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section https://ClinicalTrials.gov/show/NCT01450059 Completed Johann Wolfgang Goethe University Hospital 2014-04-30
NCT01447680 Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing https://ClinicalTrials.gov/show/NCT01447680 Completed G & W Laboratories Inc. 2012-12-31
NCT01414660 Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation https://ClinicalTrials.gov/show/NCT01414660 Completed University Hospital, Lille 2018-02-28
NCT01377272 Spatial Epidemiology of HIV Infection https://ClinicalTrials.gov/show/NCT01377272 Completed National Taiwan University Hospital 2009-06-30
NCT01328158 Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection https://ClinicalTrials.gov/show/NCT01328158 Completed AbbVie 2013-12-31
NCT01322217 Managerial Database II https://ClinicalTrials.gov/show/NCT01322217 Completed University of North Carolina, Chapel Hill 2012-06-30
NCT04422418 Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi https://ClinicalTrials.gov/show/NCT04422418 Recruiting Khalifa University for Science and Technology 2020-12-14
NCT04356053 Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care. https://ClinicalTrials.gov/show/NCT04356053 Recruiting University Hospital, Montpellier 2021-12-01
NCT04295733 Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency https://ClinicalTrials.gov/show/NCT04295733 Recruiting Ospedale Policlinico San Martino 2021-02-06
NCT04172467 Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients https://ClinicalTrials.gov/show/NCT04172467 Recruiting AIO-Studien-gGmbH 2020-12-31
NCT04172181 Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID https://ClinicalTrials.gov/show/NCT04172181 Active, not recruiting Children’s Hospital of Fudan University 2022-10-31
NCT04062799 Immunophenotype of Risk in Older Patients Admitted for Pneumonia https://ClinicalTrials.gov/show/NCT04062799 Recruiting Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2020-06-30
NCT04049084 An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID https://ClinicalTrials.gov/show/NCT04049084 Enrolling by invitation Orchard Therapeutics 2035-08-31
NCT03984552 Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children https://ClinicalTrials.gov/show/NCT03984552 Recruiting The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 2020-06-05
NCT03922958 Immunoparalysis in Acute Kidney Injury After Cardiac Surgery https://ClinicalTrials.gov/show/NCT03922958 Recruiting University of Colorado, Denver 2021-02-22
NCT03920735 Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients https://ClinicalTrials.gov/show/NCT03920735 Recruiting University Hospital, Strasbourg, France 2019-07-15
NCT03881566 Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients https://ClinicalTrials.gov/show/NCT03881566 Recruiting Seoul St. Mary’s Hospital 2020-12-31
NCT03777371 Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation https://ClinicalTrials.gov/show/NCT03777371 Completed Kanuni Sultan Suleyman Training and Research Hospital 2018-12-01
NCT03721146 ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency https://ClinicalTrials.gov/show/NCT03721146 Recruiting University Hospital, Caen 2021-09-01
NCT03716700 Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN) https://ClinicalTrials.gov/show/NCT03716700 Active, not recruiting Shire 2020-07-30
NCT03668288 Tolerance and Patients’ Satisfaction With IGHy https://ClinicalTrials.gov/show/NCT03668288 Recruiting CHU de Reims 2020-08-14
NCT03648567 GLILD Diagnosed in Children and Young Adults With Common Variable Immunodeficiency https://ClinicalTrials.gov/show/NCT03648567 Recruiting Central Hospital, Nancy, France 2018-09-01
NCT03610802 Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies https://ClinicalTrials.gov/show/NCT03610802 Recruiting National Institutes of Health Clinical Center (CC) 2038-03-31
NCT03609840 Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients https://ClinicalTrials.gov/show/NCT03609840 Recruiting University of California, San Francisco 2020-07-31
NCT03583138 HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) https://ClinicalTrials.gov/show/NCT03583138 Completed Yale University 2015-12-15
NCT03575143 Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIV https://ClinicalTrials.gov/show/NCT03575143 Recruiting University of California, San Diego 2022-07-15
NCT03422614 Pathophysiology of Inborn Immunodeficiencies https://ClinicalTrials.gov/show/NCT03422614 Recruiting University of Zurich 2025-07-01
NCT03414528 Identification of New Inborn Errors of Immunity https://ClinicalTrials.gov/show/NCT03414528 Recruiting University of Zurich 2025-08-15
NCT01222741 Studies of Disorders With Increased Susceptibility to Fungal Infections https://ClinicalTrials.gov/show/NCT01222741 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01213316 A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen) https://ClinicalTrials.gov/show/NCT01213316 Completed Merck Sharp & Dohme Corp. 2015-04-30
NCT01210924 Chinese Network of Pediatric Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT01210924 Completed National Center for AIDS/STD Control and Prevention, China CDC 2015-12-31
NCT01186913 Natural History Study of SCID Disorders https://ClinicalTrials.gov/show/NCT01186913 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2028-09-30
NCT01166074 Retrospective Chart Review of Subcutaneous IgG Use in Infants https://ClinicalTrials.gov/show/NCT01166074 Completed CSL Behring 2010-12-31
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients https://ClinicalTrials.gov/show/NCT01153269 Completed Abbott 2010-11-30
NCT01097655 Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet https://ClinicalTrials.gov/show/NCT01097655 Completed AbbVie 2016-01-31
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term https://ClinicalTrials.gov/show/NCT01083810 Completed Abbott 2010-06-30
NCT01077557 Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status https://ClinicalTrials.gov/show/NCT01077557 Completed ViiV Healthcare 2011-11-30
NCT01076985 Special Investigation of Kaletra in Pregnant Women https://ClinicalTrials.gov/show/NCT01076985 Completed Abbott 2010-12-31
NCT01076972 Drug Use Investigation of Kaletra https://ClinicalTrials.gov/show/NCT01076972 Completed Abbott 2010-12-31
NCT01076179 Kaletra in Combination With Antiretroviral Agents https://ClinicalTrials.gov/show/NCT01076179 Completed AbbVie 2016-01-31
NCT01075191 Kaletra: Therapy With Double Protease Inhibitors https://ClinicalTrials.gov/show/NCT01075191 Completed AbbVie 2011-09-30
NCT01054638 HIV Treatment and CVD Events https://ClinicalTrials.gov/show/NCT01054638 Completed ViiV Healthcare 2010-12-31
NCT00914225 Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya https://ClinicalTrials.gov/show/NCT00914225 Completed University of Washington 2011-12-31
NCT00871078 Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients https://ClinicalTrials.gov/show/NCT00871078 Completed Federal University of São Paulo 2009-09-30
NCT00852943 Screening Protocol for Genetic Diseases of Allergic Inflammation https://ClinicalTrials.gov/show/NCT00852943 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00845416 Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population https://ClinicalTrials.gov/show/NCT00845416 Completed University of California, San Francisco 2011-11-30
NCT03815357 What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? https://ClinicalTrials.gov/show/NCT03815357 Recruiting Murdoch Childrens Research Institute 2021-01-31
NCT00001467 Genetic Analysis of Immune Disorders https://ClinicalTrials.gov/show/NCT00001467 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT02396355 Accuracy Evaluation of the BD FACS Presto System https://ClinicalTrials.gov/show/NCT02396355 Completed Becton, Dickinson and Company 2015-05-31
NCT00128973 Evaluation of Patients With Immune Function Abnormalities https://ClinicalTrials.gov/show/NCT00128973 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04382508 Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. https://ClinicalTrials.gov/show/NCT04382508 Enrolling by invitation University Hospital Southampton NHS Foundation Trust 2021-03-21
NCT00758992 Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages https://ClinicalTrials.gov/show/NCT00758992 Completed St. Jude Children’s Research Hospital 2015-07-31
NCT00749840 Attitudes and Beliefs and the Steps of HIV Care https://ClinicalTrials.gov/show/NCT00749840 Completed M.D. Anderson Cancer Center 2012-11-30
NCT00551655 Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00551655 Completed AIDS Arms Inc. NA
NCT00434070 Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring https://ClinicalTrials.gov/show/NCT00434070 Completed National Institutes of Health Clinical Center (CC) NA
NCT00404560 Detection and Characterization of Infections and Infection Susceptibility https://ClinicalTrials.gov/show/NCT00404560 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00394004 Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials https://ClinicalTrials.gov/show/NCT00394004 Completed National Institutes of Health Clinical Center (CC) NA
NCT00312468 Examining the Link Between Heart Disease and HIV Infection in Women https://ClinicalTrials.gov/show/NCT00312468 Completed Albert Einstein College of Medicine 2012-12-31
NCT00244803 Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2) https://ClinicalTrials.gov/show/NCT00244803 Completed Johns Hopkins University 2007-05-31
NCT00113464 Developing Newborn Screening for Infants With Primary Immunodeficiency https://ClinicalTrials.gov/show/NCT00113464 Completed National Institutes of Health Clinical Center (CC) NA
NCT00097006 Retrovirus Epidemiology Donor Study-II (REDS-II) https://ClinicalTrials.gov/show/NCT00097006 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-09-30
NCT00091884 Efficacy of Elevated CD4 Counts on CMV Retinitis https://ClinicalTrials.gov/show/NCT00091884 Completed National Institutes of Health Clinical Center (CC) NA
NCT00068978 Analysis of Immune Responses to HIV Vaccines https://ClinicalTrials.gov/show/NCT00068978 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001699 A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers https://ClinicalTrials.gov/show/NCT00001699 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001435 Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children https://ClinicalTrials.gov/show/NCT00001435 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001424 Evaluation and Natural History of Children With Cancer and AIDS https://ClinicalTrials.gov/show/NCT00001424 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001158 Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System https://ClinicalTrials.gov/show/NCT00001158 Completed National Institutes of Health Clinical Center (CC) NA
NCT00015431 Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms https://ClinicalTrials.gov/show/NCT00015431 Completed National Institutes of Health Clinical Center (CC) NA
NCT00006335 Influences on Female Adolescents’ Decisions Regarding Testing for Carrier Status of XSCID https://ClinicalTrials.gov/show/NCT00006335 Completed National Institutes of Health Clinical Center (CC) 2008-09-25
NCT00006319 Molecular and Clinical Studies of Primary Immunodeficiency Diseases https://ClinicalTrials.gov/show/NCT00006319 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT00006310 KSHV Infection in Blood Donors From Texas https://ClinicalTrials.gov/show/NCT00006310 Completed The University of Texas Health Science Center at San Antonio NA
NCT00005379 Tuberculosis in a Multiethnic Inner City Population https://ClinicalTrials.gov/show/NCT00005379 Completed NYU Langone Health 1999-07-31
NCT00005360 HIV Diversity and Pathogenesis in Donor-Recipient Clusters https://ClinicalTrials.gov/show/NCT00005360 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005353 Cardiac Autonomic Control in Children of HIV Positive Mothers https://ClinicalTrials.gov/show/NCT00005353 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005309 Prospective Study of HIV Infection in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005309 Completed Bloodworks 1995-03-31
NCT00005303 Effectiveness of AIDS Antibody Screening https://ClinicalTrials.gov/show/NCT00005303 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005301 Transfusion Safety Study (TSS) https://ClinicalTrials.gov/show/NCT00005301 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005278 Retrovirus Epidemiology Donor Study I (REDS I) https://ClinicalTrials.gov/show/NCT00005278 Completed National Heart, Lung, and Blood Institute (NHLBI) 2007-10-31
NCT00005274 Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) https://ClinicalTrials.gov/show/NCT00005274 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005273 Pulmonary Complications of HIV Infection Study (PACS) https://ClinicalTrials.gov/show/NCT00005273 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005229 HIV-Associated Heart Disease https://ClinicalTrials.gov/show/NCT00005229 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005228 AIDS-Associated Heart Disease – Incidence and Etiology https://ClinicalTrials.gov/show/NCT00005228 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005227 AIDS-Associated Cardiomyopathy https://ClinicalTrials.gov/show/NCT00005227 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001650 Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00001650 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001611 Immune Activity Against CVM Retinitis https://ClinicalTrials.gov/show/NCT00001611 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001560 Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers https://ClinicalTrials.gov/show/NCT00001560 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001500 Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits https://ClinicalTrials.gov/show/NCT00001500 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001353 Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs https://ClinicalTrials.gov/show/NCT00001353 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001336 In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients https://ClinicalTrials.gov/show/NCT00001336 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001255 Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study https://ClinicalTrials.gov/show/NCT00001255 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000168 Longitudinal Study of Ocular Complications of AIDS (LSOCA) https://ClinicalTrials.gov/show/NCT00000168 Completed Johns Hopkins Bloomberg School of Public Health 2013-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04459689 COVID-19 in PID Survey https://ClinicalTrials.gov/show/NCT04459689 Recruiting Imagine Institute 2022-03-31
NCT02264509 Peripheral Arterial Insufficiency Associated With HIV/AIDS https://ClinicalTrials.gov/show/NCT02264509 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2014-11-30
NCT01287689 Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study https://ClinicalTrials.gov/show/NCT01287689 Completed Technische Universität Dresden 2016-12-31
NCT03037359 A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products https://ClinicalTrials.gov/show/NCT03037359 Active, not recruiting ADMA Biologics, Inc. 2021-03-31
NCT01997359 Multi-level Determinants of Starting ART Late: Aim 3 https://ClinicalTrials.gov/show/NCT01997359 Completed Columbia University 2014-04-30
NCT01992887 Pre-ART Retention in Care in Tanzania https://ClinicalTrials.gov/show/NCT01992887 Completed Columbia University 2014-08-31
NCT03690063 Nice Human Immunodeficiency Virus (HIV) Cohort https://ClinicalTrials.gov/show/NCT03690063 Recruiting Centre Hospitalier Universitaire de Nice 1996-01-31
NCT03618147 Primary Immunodeficiency in Kuwait https://ClinicalTrials.gov/show/NCT03618147 Completed Kuwait Society for Allergy and Clinical Immunology 2019-05-01
NCT03576742 Severe Immune Cytopenia Registry Www.Sic-reg.Org https://ClinicalTrials.gov/show/NCT03576742 Recruiting Medical University of Graz 2022-03-08
NCT03478670 Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) https://ClinicalTrials.gov/show/NCT03478670 Enrolling by invitation Orchard Therapeutics 2037-05-31
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) https://ClinicalTrials.gov/show/NCT04354818 Recruiting Kirby Institute 2022-04-27
NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen https://ClinicalTrials.gov/show/NCT01890486 Recruiting Wake Forest University Health Sciences 2023-05-31